Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova +14 more
wiley +1 more source
Stages of objective memory impairment are associated with accelerated brain aging. [PDF]
Flo BK +5 more
europepmc +1 more source
Early Stages Arc Volcanism in the Eastern Himalayan Synstaxis, Yarlung Zongbo Suture Zone, Tibet, China: New Zircon Age, Hf Isotopic, Geochemical Constrains and Implication for the Tectonic Evolution History of Neo‐Tethys [PDF]
Yuan Li +5 more
openalex +1 more source
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Multi-Stage transcriptomic dissection identifies key molecular determinants of chicken follicular development. [PDF]
Bai Y +8 more
europepmc +1 more source
Risk Factors and Quality of Life in Patients With Geographic Atrophy, a Late Stage of Age-Related Macular Degeneration: Findings From the Korea National Health and Nutrition Examination Survey [PDF]
Yeji Kim +3 more
openalex +1 more source
A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer [PDF]
Thomas E. Stinchcombe +15 more
openalex +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

